SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection

Clinical trial NCT07096882 · RECRUITING

Trial details

NCT number: NCT07096882
Sponsor: Cytocraft Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2025-07-26
Primary completion: 2027-06-26
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.